BETTER THERAPEUTICS INC's ticker is and the CUSIP is 08773T104. A total of 16 filers reported holding BETTER THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $357,069 | -29.8% | 330,619 | -52.7% | 0.00% | -33.3% |
Q1 2023 | $508,903 | -44.1% | 699,042 | -14.1% | 0.00% | -40.0% |
Q4 2022 | $911,183 | -48.2% | 813,556 | -18.6% | 0.01% | -50.0% |
Q3 2022 | $1,760,000 | +12.8% | 1,000,000 | 0.0% | 0.01% | +11.1% |
Q2 2022 | $1,560,000 | -31.3% | 1,000,000 | -12.8% | 0.01% | -18.2% |
Q1 2022 | $2,272,000 | -63.8% | 1,147,400 | -15.0% | 0.01% | -64.5% |
Q4 2021 | $6,278,000 | – | 1,350,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $1,560,000 | 0.01% |
Tower Research Capital LLC (TRC) | 14,627 | $23,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 73,800 | $115,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 65 | $0 | 0.00% |
NORTHERN TRUST CORP | 16,703 | $26,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 37,944 | $59,000 | 0.00% |
STATE STREET CORP | 45,200 | $71,000 | 0.00% |
MORGAN STANLEY | 93,973 | $147,000 | 0.00% |
BlackRock Inc. | 75,948 | $118,000 | 0.00% |